Michael Platt of the Wharton School, Perelman School of Medicine and School of Arts and Sciences discusses how primates respond to a reward-donation task.
Jonathan Moreno of the Perelman School of Medicine and the School of Arts and Sciences comments on a report released by Donald Trump’s health-care provider.
The amygdala, a small structure at the front end of the brain’s temporal lobe, has long been associated with negative behaviors generally, and specifically with fear. But new research from Michael Platt, the James S.
Despina Kontos of the Perelman School of Medicine is quoted as one of the co-authors of a study that revealed breast tissue density might be lower for women who use aspirin.
Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s disease in the years that followed than those who didn’t undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers
Medical students in Emergency Departments often perform an initial evaluation of stable patients prior to supervising residents or attending physicians, who meanwhile provide care to other patients.
One-Two Punch of Palbociclib and Paclitaxel Shows Promise Against Advanced Breast Cancer in Penn Study
Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Aspirin Use Does Not Improve Outcomes for Cancer Patients, but May Lower Breast Tissue Density, Allowing for Earlier Detection, Two Penn Studies Find
Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, one new study from Penn Medicine suggests otherwise.